These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 16224241

  • 1. Implications of treatment-induced mucosal barrier injury.
    Blijlevens NM.
    Curr Opin Oncol; 2005 Nov; 17(6):605-10. PubMed ID: 16224241
    [Abstract] [Full Text] [Related]

  • 2. Cytotoxic treatment-induced gastrointestinal symptoms.
    Blijlevens NM.
    Curr Opin Support Palliat Care; 2007 Apr; 1(1):16-22. PubMed ID: 18660719
    [Abstract] [Full Text] [Related]

  • 3. Updated clinical practice guidelines for the prevention and treatment of mucositis.
    Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, Migliorati CA, McGuire DB, Hutchins RD, Peterson DE, Mucositis Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology.
    Cancer; 2007 Mar 01; 109(5):820-31. PubMed ID: 17236223
    [Abstract] [Full Text] [Related]

  • 4. Diagnosis and management of oral mucositis.
    Silverman S.
    J Support Oncol; 2007 Feb 01; 5(2 Suppl 1):13-21. PubMed ID: 17366929
    [Abstract] [Full Text] [Related]

  • 5. Palifermin: role in the prevention of chemotherapy- and radiation-induced mucositis.
    McDonnell AM, Lenz KL.
    Ann Pharmacother; 2007 Jan 01; 41(1):86-94. PubMed ID: 17190850
    [Abstract] [Full Text] [Related]

  • 6. [Mucositis--a major non-hematologic complication of high-dose chemotherapy and radiotherapy--pathogenesis, prevention and treatment].
    Piatkowska-Jakubas B, Darczuk D, Chomyszyn-Gajewska M, Skotnicki AB.
    Przegl Lek; 2003 Jan 01; 60(12):815-20. PubMed ID: 15058023
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Regimen-related gastrointestinal toxicities in cancer patients.
    Sonis ST.
    Curr Opin Support Palliat Care; 2010 Mar 01; 4(1):26-30. PubMed ID: 20040879
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. New strategies for management of oral mucositis in cancer patients.
    Peterson DE.
    J Support Oncol; 2006 Feb 01; 4(2 Suppl 1):9-13. PubMed ID: 16499139
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mucosal protection by cytokines.
    Hofmeister CC, Stiff PJ.
    Curr Hematol Rep; 2005 Nov 01; 4(6):446-53. PubMed ID: 16232381
    [Abstract] [Full Text] [Related]

  • 15. Intestinal mucositis: mechanisms and management.
    Keefe DM.
    Curr Opin Oncol; 2007 Jul 01; 19(4):323-7. PubMed ID: 17545794
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Palifermin as treatment in dose-intense conventional polychemotherapy induced mucositis.
    Hueber AJ, Leipe J, Roesler W, Kalden JR, Kallert S, Rech J.
    Haematologica; 2006 Aug 01; 91(8 Suppl):ECR32. PubMed ID: 16923516
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.